Cargando…
Fingolimod ameliorates chronic experimental autoimmune neuritis by modulating inflammatory cytokines and Akt/mTOR/NF‐κB signaling
OBJECTIVE: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated disease that targets the myelin sheaths of the peripheral nerves. Fingolimod is a sphingosine 1 phosphate (S1P) receptor antagonist with a high affinity for S1P receptors through the Akt–mTOR pathway, a...
Autores principales: | Feng, Yuan, Feng, Fang, Pan, Shuyi, Zhang, Jiewen, Li, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097075/ https://www.ncbi.nlm.nih.gov/pubmed/36917739 http://dx.doi.org/10.1002/brb3.2965 |
Ejemplares similares
-
Dioscin Ameliorates Experimental Autoimmune Thyroiditis via the mTOR and TLR4/NF-κB Signaling
por: Zhang, Chengfei, et al.
Publicado: (2023) -
Siponimod ameliorates experimental autoimmune neuritis
por: Uchi, Takafumi, et al.
Publicado: (2023) -
Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection
por: Ambrosius, Björn, et al.
Publicado: (2017) -
Blocking Thrombin Significantly Ameliorates Experimental Autoimmune Neuritis
por: Shavit-Stein, Efrat, et al.
Publicado: (2019) -
Targeting the PI3K/AKT/mTOR/NFκB Axis in Ovarian Cancer
por: Ghoneum, Alia, et al.
Publicado: (2020)